New blood test aims to catch prostate cancer earlier and more accurately

NCT ID NCT06604130

First seen Dec 10, 2025 · Last updated May 15, 2026 · Updated 18 times

Summary

This study is testing a new blood test that looks at genetic material (RNA) from tiny particles in the blood (exosomes) to diagnose prostate cancer. The goal is to see if this test is more accurate than current methods, potentially reducing the need for invasive biopsies. The study will involve 1600 men with elevated PSA levels who are already scheduled for a prostate biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Yan'an University,

    Yan’an, Shaanxi, 716000, China

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, 750000, China

  • Qinghai University Affiliated Hospital

    Xining, Qinghai, 810000, China

  • Shaanxi Provincial People's Hospital

    Xi'an, Shaanxi, 710000, China

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, 730000, China

  • The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

    Xianyang, Shaanxi, 712000, China

  • Weinan Central Hospital

    Weinan, Shaanxi, 714000, China

  • Xijing 986 Hospital

    Xi'an, Shaanxi, 710000, China

  • Xijing Hospital

    Xi'an, Shaanxi, 710032, China

Conditions

Explore the condition pages connected to this study.